Failure to Reach a Consensus in Polypharmacy Definition: An Obstacle to Measuring Risks and Impacts—Results of a Literature Review

Taghy N, Cambon L, Cohen JM, Dussart C

Therapeutics and Clinical Risk Management 2020, 16:57-73

Published Date: 11 February 2020